Otros idiomas Nocturne Acquisition Corporation

Acciones

MBTC

KYG6580S1140

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 03/04/2024			Varia. Cinco días.	Varia. 1 de enero.
11,66 ^USD	-0,49 %		-.--%	+0,08 %

31/03	Cognos Therapeutics Inc. canceló la adquisición de Nocturne Acquisition Corporation (NasdaqCM:MBTC) a un grupo de accionistas en una operación de fusión inversa.	CI
07/02	Nocturne Acquisition Corporation anuncia cambios en la dirección	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Nocturne Acquisition Corporation(NasdaqCM:MBTC) dropped from NASDAQ Composite Index	03/04
Cognos Therapeutics Inc. cancelled the acquisition of Nocturne Acquisition Corporation from a group of shareholders in a reverse merger transaction.	31/03
Nocturne Acquisition Corporation Announces Management Changes	07/02
Sector Update: Financial Stocks Ease Late Afternoon	05/02
Sector Update: Financial	05/02
Nocturne Acquisition Shares Jump as Stockholders' Vote on Merger With Cognos Therapeutics Postponed Further	05/02
Nocturne Acquisition Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	22/11
Chardan Engaged to Facilitate Nocturne Acquisition Corporation's Business Combination with Cognos Therapeutics, Inc., Paving the Way for NASDAQ Listing	21/09/23
Nocturne Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	21/08/23
Nocturne Acquisition Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23/06/23
Nocturne Acquisition Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	26/05/23
Nocturne Acquisition Corporation Auditor Raises 'Going Concern' Doubt	26/05/23
NOCTURNE ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	02/05/23
NOCTURNE ACQUISITION CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	14/04/23
NOCTURNE ACQUISITION CORP : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	06/04/23
NOCTURNE ACQUISITION CORP : Regulation FD Disclosure (form 8-K)	03/04/23
NOCTURNE ACQUISITION CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	09/01/23
NOCTURNE ACQUISITION CORP : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	04/01/23
Nocturne Acquisition in Deal to Merge With Cognos Therapeutics	03/01/23
Cognos Therapeutics Inc. executed a definitive business combination agreement to acquire Nocturne Acquisition Corporation from Nocturne Sponsor, LLC, Polar Asset Management Partners Inc., Periscope Capital Inc, Sea Otter Advisors LLC and others for approximately $120 million in a reverse merger transaction.	03/01/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Nocturne Acquisition Corporation

Acciones

MBTC

KYG6580S1140

Otros idiomas

Filtros